NCT00558922 - A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

AEG35156

AEG35156 will be given as a 2-hour intravenous infusion once weekly with a 2-hour loading dose given daily in the 2 days immediately prior to Day 1 (on Days -2 and -1) only in Cycle 1.

Trial Locations (6)

23502

Virginia Oncology Associates, Norfolk

29605

Cancer Centers of the Carolinas, Greenville

45409

Dayton Oncology & Hematology, P.A., Dayton

46219

Central Indiana Cancer Center, Indianapolis

80218

Rocky Mountain Cancer Center, Denver

98684

Northwest Cancer Specialists, P. C., Vancouver